We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURN icon
2451
Huron Consulting
HURN
$2.42B
$6.83K ﹤0.01%
55
+14
+34% +$1.64K
BFS
2452
Saul Centers
BFS
$839M
$6.83K ﹤0.01%
176
-8
-4% -$321
AAMI
2453
Acadian Asset Management
AAMI
$3.22B
$6.82K ﹤0.01%
259
+95
+58% +$2.66K
KYMR icon
2454
Kymera Therapeutics
KYMR
$9.03B
$6.8K ﹤0.01%
169
-13
-7% -$587
LBTYK icon
2455
Liberty Global Class C
LBTYK
$3.41B
$6.74K ﹤0.01%
513
+211
+70% +$3.64K
UPBD icon
2456
Upbound Group
UPBD
$1.12B
$6.74K ﹤0.01%
231
-44
-16% -$1.37K
ASTS icon
2457
AST SpaceMobile
ASTS
$20.5B
$6.73K ﹤0.01%
319
+184
+136% +$4.49K
TALO icon
2458
Talos Energy
TALO
$2.6B
$6.73K ﹤0.01%
693
+141
+26% +$1.48K
CVLG icon
2459
Covenant Logistics
CVLG
$843M
$6.71K ﹤0.01%
246
+58
+31% +$1.59K
APGE icon
2460
Apogee Therapeutics
APGE
$10.2B
$6.7K ﹤0.01%
148
+116
+363% +$5.92K
ASTH icon
2461
Astrana Health
ASTH
$1.86B
$6.68K ﹤0.01%
212
-368
-63% -$17.5K
FISI icon
2462
Financial Institutions
FISI
$814M
$6.66K ﹤0.01%
244
+38
+18% +$1K
PACS icon
2463
PACS Group
PACS
$7.67B
$6.65K ﹤0.01%
+507
New +$13K
INSE icon
2464
Inspired Entertainment
INSE
$161M
$6.63K ﹤0.01%
733
-2
-0.3% -$19
CORZ icon
2465
Core Scientific
CORZ
$6.25B
$6.6K ﹤0.01%
470
+134
+40% +$1.98K
DSGN icon
2466
Design Therapeutics
DSGN
$897M
$6.6K ﹤0.01%
1,070
+653
+157% +$3.78K
DYN icon
2467
Dyne Therapeutics
DYN
$4.95B
$6.6K ﹤0.01%
280
+43
+18% +$1.27K
TRP icon
2468
TC Energy
TRP
$66B
$6.56K ﹤0.01%
141
SFL icon
2469
SFL Corp
SFL
$1.58B
$6.55K ﹤0.01%
641
+436
+213% +$4.66K
TG icon
2470
Tredegar Corp
TG
$292M
$6.54K ﹤0.01%
852
+677
+387% +$5.15K
ACMR icon
2471
ACM Research
ACMR
$5.49B
$6.54K ﹤0.01%
433
+58
+15% +$1.05K
AMSC icon
2472
American Superconductor
AMSC
$1.5B
$6.53K ﹤0.01%
265
+57
+27% +$1.57K
PAGP icon
2473
Plains GP Holdings
PAGP
$4.98B
$6.53K ﹤0.01%
355
-127
-26% -$2.36K
VSH icon
2474
Vishay Intertechnology
VSH
$5.08B
$6.5K ﹤0.01%
384
-191
-33% -$3.35K
CGEM icon
2475
Cullinan Oncology
CGEM
$1.18B
$6.48K ﹤0.01%
532
-50
-9% -$719

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.